alprenolol has been researched along with spironolactone in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| Kesler, DF | 1 |
3 other study(ies) available for alprenolol and spironolactone
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
[Prevention of frequent paroxysmal ventricular tachycardia by combined use of anti-arrhythmia drugs].
Topics: Aged; Alprenolol; Anti-Arrhythmia Agents; Drug Therapy, Combination; Humans; Lanatosides; Male; Middle Aged; Procainamide; Recurrence; Spironolactone; Strophanthins; Tachycardia, Paroxysmal | 1981 |